Literature DB >> 2894458

Effects of selective 5-hydroxytryptamine-2 and nonselective 5-hydroxytryptamine antagonists on the differential-reinforcement-of-low-rate 72-second schedule.

G J Marek1, L S Seiden.   

Abstract

The effects of antidepressant drugs, administered with and without a 5-hydroxytryptamine (5-HT) antagonist that is not selective for 5-HT receptor subtypes, were assessed in rats responding under a differential-reinforcement-of-low-rate 72-second (DRL 72-s) schedule of reinforcement. The increases in reinforcement rate seen after low dose tricyclic antidepressant drug administration were antagonized by the 5-HT antagonist methysergide. Methysergide did not antagonize either the increases in reinforcement rate or the decreases in response rate induced by the atypical antidepressant trazodone or the putative antidepressant clenbuterol. In addition, the effects of 5-HT receptor antagonists with varying selectivity for the 5-HT2 relative to the 5-HT1 receptor subtypes were assessed when administered alone. The rank order potency series for the maximal increase in the reinforcement rate after administration of the 5-HT antagonists was ketanserin greater than pipamperone greater than trazodone greater than cyproheptadine greater than cinanserin greater than metergoline greater than methysergide, in close agreement with the selectivity of these drugs for the 5-HT2 relative to the 5-HT1 receptor subtypes. In addition, the specificity of the DRL 72-s schedule was further assessed with the alpha adrenergic antagonists phentolamine and phenoxybenzamine which both decreased the response rate but did not increase the reinforcement rate as do antidepressant drugs. These results suggest that the therapeutic effect of atypical antidepressants such as trazodone and mianserin may be related to selective antagonism of 5-HT2 receptors. Furthermore, agonist action at a 5-HT1 receptor and antagonist action at 5-HT2 receptors both appear to contribute to antidepressant-like activity on the DRL 72-s schedule.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2894458

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats.

Authors:  F Jenck; C L Broekkamp; A M Van Delft
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Selective inhibition of MAO-A, not MAO-B, results in antidepressant-like effects on DRL 72-s behavior.

Authors:  G J Marek; L S Seiden
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

3.  A quantitative interresponse-time analysis of DRL performance differentiates similar effects of the antidepressant desipramine and the novel anxiolytic gepirone.

Authors:  J B Richards; L S Seiden
Journal:  J Exp Anal Behav       Date:  1991-09       Impact factor: 2.468

4.  Effects of salbutamol upon performance on an operant screen for antidepressants.

Authors:  R T Dunn; J B Richards; L S Seiden
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 5.  Dissecting impulsivity and its relationships to drug addictions.

Authors:  J David Jentsch; James R Ashenhurst; M Catalina Cervantes; Stephanie M Groman; Alexander S James; Zachary T Pennington
Journal:  Ann N Y Acad Sci       Date:  2014-03-21       Impact factor: 5.691

6.  Comparison of the effects of mianserin and its enantiomers and metabolites on a behavioral screen for antidepressant activity.

Authors:  T H Hand; G J Marek; L S Seiden
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

7.  Buspirone, gepirone, ipsapirone, and zalospirone have distinct effects on the differential-reinforcement-of-low-rate 72-s schedule when compared with 5-HTP and diazepam.

Authors:  J B Richards; K E Sabol; T H Hand; D C Jolly; G J Marek; L S Seiden
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.